Dimethylformamide → tert-butyl(2S,3S)-7-cyano-2-methyl-1-(2-(methylsulfonyl)acetyl)-4-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylcarbamate
반응식
Br[C:2]1[CH:29]=[CH:28][C:5]2[N:6]([C:21](=[O:27])[CH2:22][S:23]([CH3:26])(=[O:25])=[O:24])[C@@H:7]([CH3:20])[C@H:8]([NH:12][C:13](=[O:19])[O:14][C:15]([CH3:18])([CH3:17])[CH3:16])[C:9](=[O:11])[NH:10][C:4]=2[CH:3]=1.[CH3:30][N:31](C=O)C>[C-]#N.[Zn+2].[C-]#N>[C:30]([C:2]1[CH:29]=[CH:28][C:5]2[N:6]([C:21](=[O:27])[CH2:22][S:23]([CH3:26])(=[O:25])=[O:24])[C@@H:7]([CH3:20])[C@H:8]([NH:12][C:13](=[O:19])[O:14][C:15]([CH3:18])([CH3:16])[CH3:17])[C:9](=[O:11])[NH:10][C:4]=2[CH:3]=1)#[N:31]참가 물질
반응물 2
생성물 1
시약·촉매·용매 1
반응 조건
- 온도
- 110 °C
실험 절차
A solution of tert-butyl(2S,3S)-7-bromo-2-methyl-1-(2-(methylsulfonyl)acetyl)-4-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylcarbamate (124 mg, 253 μmol) in DMF (2.53 ml) was sparged with Ar for 10 min, then zinc cyanide (59.4 mg, 506 μmol) and tetrakis(triphenyl-phosphine)palladium(0) (29.2 mg, 25.3 μmol) were added. The mixture was sparged with Ar for an additional 5 min, then sealed and heated in the microwave at 110° C. for 20 min, then diluted with H2O and extracted with EtOAc. The combined organic layers were washed with H2O and sat. aq. NaCl, dried over Na2SO4, filtered, and concentrated. The crude material was purified by flash chromatography to provide tert-butyl(2S,3S)-7-cyano-2-methyl-1-(2-(methylsulfonyl)acetyl)-4-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylcarbamate (104 mg, 94%) as a white solid. MS m/z 459 (MNa)+.
후처리
- customThe mixture was sparged with Ar for an additional 5 min
- customsealed
- additiondiluted with H2O
- extractionextracted with EtOAc
- washThe combined organic layers were washed with H2O and sat. aq. NaCl
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customThe crude material was purified by flash chromatography
출처 및 근거
- ORD 기록
- ord-16098328f528415aa9a554c3f1ee4001
- 출처 데이터셋
- uspto-grants-2016_08
- 특허 번호
- US09422331B2
반응 노트
불러오는 중…